ArticleMolecules (Basel, Switzerland)2023
Fabricating BiOCl Nanoflake/FeOCl Nanospindle Heterostructures for Efficient Visible-Light Photocatalysis.
Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unique Four-Layer Core-Shell NaYFMolecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fabricating heterostructures with abundant interfaces and delicate nanoarchitectures is an attractive approach for optimizing photocatalysts. Herein, we report the facile synthesis of BiOCl nanoflake/FeOCl nanospindle heterostructures through a solution chemistry method at room temperature. Characterizations, including XRD, SEM, TEM, EDS, and XPS, were employed to investigate the synthesized materials. The results demonstrate that the in situ reaction between the Bi precursors and the surface Cl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.